Company intelligence / Profile preview

Sahajanand Medical Technologies

Surat, Gujarat, Indiasmtpl.com ↗

Ownership: Private
Employees: ~1001
Development stage: Commercial

Overview

Sahajanand Medical Technologies (SMT) has a strong track record of clinical validation for its products. Its coronary stents and related devices have been evaluated in rigorous clinical trials and published in leading medical journals such as The Lancet and New England Journal of Medicine. The company’s drug-eluting stents are widely used globally with demonstrated safety and efficacy

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

Supraflex Cruz

Commercial

Indications: Coronary Artery Disease

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Sahajanand Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sahajanand Medical Technologies.

Explore the full profile